{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Labcorp Holdings Experiences Valuation Adjustment Amid Strong Market Performance
Labcorp Holdings, Inc. has recently adjusted its valuation, with its current price at $285.94. The company has shown strong performance over the past year, achieving a 32.91% return, significantly outperforming the S&P 500. Key financial metrics indicate Labcorp's competitive positioning within the Pharmaceuticals & Biotechnology sector.
Labcorp Holdings, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance
Labcorp Holdings, Inc. has recently revised its evaluation amid current market dynamics. The stock has shown strong performance over the past year, significantly outperforming the S&P 500. Technical indicators present mixed signals, with bullish trends in some areas and bearish indicators in others, reflecting a complex market environment.
Is Labcorp Holdings, Inc. overvalued or undervalued?
As of October 17, 2025, Labcorp Holdings, Inc. is fairly valued with a P/E ratio of 28.86, an EV to EBITDA of 14.80, and a PEG ratio of 0.0, indicating premium pricing compared to peers, while outperforming the S&P 500 with a year-to-date return of 24.69%.
Is Labcorp Holdings, Inc. overvalued or undervalued?
As of October 17, 2025, Labcorp Holdings, Inc. is fairly valued with a P/E ratio of 28.86 and has outperformed the S&P 500 with a year-to-date return of 24.69%.
Labcorp Holdings Hits New 52-Week High of $289.19
Labcorp Holdings, Inc. achieved a new 52-week high of USD 289.19 on October 1, 2025, highlighting its strong position in the Pharmaceuticals & Biotechnology industry. The company has outperformed the S&P 500 over the past year, reflecting significant market momentum and robust financial metrics.
Labcorp Holdings Hits New 52-Week High at $288.24
Labcorp Holdings, Inc. achieved a new 52-week high of USD 288.24 on September 30, 2025, highlighting its strong position in the Pharmaceuticals & Biotechnology sector. The company has shown resilience over the past year, with significant stock performance and ongoing engagement in the competitive market landscape.
Is Labcorp Holdings, Inc. technically bullish or bearish?
As of October 1, 2023, Labcorp Holdings, Inc. shows a bullish overall technical stance with strong MACD signals and positive performance, despite some caution from Dow Theory on the monthly timeframe.
Is Labcorp Holdings, Inc. overvalued or undervalued?
As of February 6, 2025, Labcorp Holdings, Inc. is fairly valued with a P/E ratio of 28.86 and has outperformed the S&P 500 year-to-date with a return of 20.86%, although it has lagged behind the index over the past three to five years.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
